# Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life

> **NCT03420235** · NA · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 90 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **OTHER:** Home monitoring program

## Key facts

- **NCT ID:** NCT03420235
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-09
- **Primary completion:** 2019-08-26
- **Final completion:** 2019-08-26
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2020-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03420235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03420235, "Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03420235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*